Optima Medical Innovations Corp. (TOKIF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2020 | 2019 | 2018 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -320.48 Thousand | -2.22 Million | -1.46 Million | -68.73 Thousand | -100.38 Thousand | -143.39 Thousand |
| Net Income | -4.17 Million | -18.04 Million | -14.9 Million | -137.58 Thousand | -90.25 Thousand | -444.11 Thousand |
| Depreciation & Amortization | -727.74 Thousand | -1.35 Million | 169.85 Thousand | 65.81 Thousand | 38.14 Thousand | - |
| Deferred income taxes | 689.13 Thousand | -409.35 Thousand | - | - | - | - |
| Stock-based compensation | 766.35 Thousand | 3.11 Million | 508.81 Thousand | 4.53 Million | 171.05 Thousand | - |
| Change in working capital | 648.05 Thousand | 306.22 Thousand | 1.77 Million | 68.32 Thousand | -10.12 Thousand | 45.57 Thousand |
| Other non-cash items | 2.47 Million | 14.15 Million | 10.05 Million | -21.41 Thousand | 356.29 Thousand | -11.39 Thousand |
| Investing Cash Flow | -5794.76 | -259.62 Thousand | 347.78 Thousand | -300.41 Thousand | - | - |
| Investments in PPE | -5794.76 | -259.62 Thousand | -428.35 Thousand | -300.41 Thousand | - | - |
| Acquisitions | - | - | 776.13 Thousand | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -150 Thousand | - | - | - |
| Financing Cash Flow | 431.22 Thousand | 1.02 Million | 2.36 Million | 201.03 Thousand | 703.39 Thousand | - |
| Debt repayment | -446.27 Thousand | -329.29 Thousand | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 136.77 Thousand | 1.36 Million | 2.36 Million | - | - | - |
| Other Financing Activities | 740.72 Thousand | -7655.00 | 2.72 Million | -78.16 Thousand | 703.39 Thousand | - |
| Accounts receivables | -35.34 Thousand | 318.43 Thousand | -175.5 Thousand | -23.03 Thousand | 765.00 | - |
| Accounts payables | -317.49 Thousand | -192.04 Thousand | 1.82 Million | - | - | - |
| Inventory | 14.89 Thousand | 108.36 Thousand | 124.39 Thousand | -145.56 Thousand | -78.1 Thousand | - |
| Other working capital | 986 Thousand | 71.47 Thousand | -811.40 | 3299.00 | 41.44 Thousand | - |
| Cash at beginning of period | 63.43 Thousand | 1.46 Million | 56.41 Thousand | 56.41 Thousand | 157.35 Thousand | 311.46 Thousand |
| Cash at end of period | 105.24 Thousand | 63.43 Thousand | 1.46 Million | 190.58 Thousand | 56.41 Thousand | 157.35 Thousand |
| Capital Expenditure | -5794.76 | -259.62 Thousand | -428.35 Thousand | -300.41 Thousand | - | - |
| Effect of forex changes on cash | -57.86 Thousand | 24.66 Thousand | 136.52 Thousand | 1871.00 | -557.00 | -10.71 Thousand |
| Net cash flow / Change in cash | 41.81 Thousand | -1.4 Million | 1.41 Million | 134.16 Thousand | -100.93 Thousand | -154.11 Thousand |
| Free Cash Flow | -326.27 Thousand | -2.48 Million | -1.89 Million | -369.15 Thousand | -100.38 Thousand | -143.39 Thousand |
| Breakdown | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 FY | 2020 Q4 | 2020 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -259.06 Thousand | 29.85 Thousand | -77.99 Thousand | -4.17 Million | -57.2 Thousand | -105.05 Thousand |
| Depreciation & Amortization | 133.51 Thousand | 139.04 Thousand | 137.14 Thousand | -727.74 Thousand | 196.53 Thousand | 150.98 Thousand |
| Deferred income taxes | - | - | - | 689.13 Thousand | - | - |
| Stock-based compensation | 35.35 Thousand | 52.42 Thousand | 84.92 Thousand | 766.35 Thousand | -57.43 Thousand | 166.72 Thousand |
| Change in working capital | 38.04 Thousand | -127.35 Thousand | -50.69 Thousand | 648.05 Thousand | -1.29 Million | -2.23 Million |
| Other non-cash items | 357.82 Thousand | 477 Thousand | 233.22 Thousand | 2.47 Million | 666.82 Thousand | 48.19 Thousand |
| Investing Cash Flow | -6197.56 | - | - | -5794.76 | -51.00 | -44.00 |
| Investments in PPE | -6197.56 | - | - | -5794.76 | -51.00 | -44.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -66.09 Thousand | -101.29 Thousand | 17.53 Thousand | 431.22 Thousand | -785.3 Thousand | -2265.00 |
| Debt repayment | -17.17 Thousand | -50.54 Thousand | -67.13 Thousand | -446.27 Thousand | -48.04 Thousand | -64.75 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | -713.49 Thousand | - |
| Common Stock Issuance | - | - | - | 136.77 Thousand | -713.49 Thousand | 19.57 Thousand |
| Other Financing Activities | -17.47 Thousand | -49.15 Thousand | 66.63 Thousand | 740.72 Thousand | -32.1 Thousand | 51.68 Thousand |
| Accounts receivables | 190.57 Thousand | -68.41 Thousand | 73.59 Thousand | -35.34 Thousand | 1.33 Million | -99.24 Thousand |
| Accounts payables | -153.22 Thousand | -55.39 Thousand | -131.58 Thousand | -317.49 Thousand | -11.07 Million | -179.14 Thousand |
| Inventory | 56.02 | -30.81 | -26.19 | 14.89 Thousand | 5.08 Million | -14.76 Thousand |
| Other working capital | 633.35 | -3518.16 | 7326.32 | 986 Thousand | 3.36 Million | -1.94 Million |
| Cash at beginning of period | -5.60 | - | 105.24 Thousand | 63.43 Thousand | 880.55 Thousand | 3 Million |
| Cash at end of period | 112.83 | 1232.00 | -541.00 | 105.24 Thousand | 105.24 Thousand | 880.55 Thousand |
| Capital Expenditure | -6197.56 | - | - | -5794.76 | -51.00 | -44.00 |
| Effect of forex changes on cash | 31.7 Thousand | -14.08 Thousand | -32.7 Thousand | -57.86 Thousand | -136.73 Thousand | -145.46 Thousand |
| Net cash flow / Change in cash | 118.44 | 1232.00 | -105.78 Thousand | 41.81 Thousand | -775.31 Thousand | -2.12 Million |
| Free Cash Flow | 34.5 Thousand | 116.61 Thousand | -90.61 Thousand | -326.27 Thousand | 146.72 Thousand | -1.97 Million |
002322
4552
BAC
1452
1OJ
VEDL